drugset / Trial / NCT07458061
Kamuvudine-9 (K9) in Diabetic Macular Edema
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objectives of this investigation are to assess: 1. whether oral K9 is safe in subjects with DME, and 2. whether oral K9 improves BCVA compared to oral placebo
Timeline
- Start
- 2026-02
- Primary completion
- 2026-06
- Completion
- 2026-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Kamuvudine K9 | Unknown | — | Oral |